Crossmark

Linking in vitro and ex vivo CB1 activity with serum concentrations and clinical features in 5F-MDMB-PICA users to better understand SCRAs and their metabolites

Crossref DOI link: https://doi.org/10.1007/s00204-022-03355-6

Published Online: 2022-08-12

Published Print: 2022-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Janssens, Liesl K. https://orcid.org/0000-0001-9740-5036
Hudson, Simon https://orcid.org/0000-0001-6640-5463
Wood, David M. https://orcid.org/0000-0002-7826-7237
Wolfe, Caitlin https://orcid.org/0000-0003-0241-7566
Dargan, Paul I. https://orcid.org/0000-0002-3433-9622
Stove, Christophe P. https://orcid.org/0000-0001-7126-348X
Funding

Funding for this research was provided by:

Bijzonder Onderzoeksfonds UGent (BOF20/DOC/051)
License Information

Text and Data Mining valid from 2022-08-12

Version of Record valid from 2022-08-12
More Information

Article History

Received: 1 June 2022

Accepted: 2 August 2022

First Online: 12 August 2022

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below